Business

July 1, 2014

Upbeat test results push Salix shares higher

Salix Pharmaceutical shares closed 14 percent higher Tuesday after the Raleigh-based drug company announced upbeat test results for its best-selling drug.

Related content

Comments

Videos

Editor's Choice Videos